Hysingla ER (Purdue Pharma LP)


Welcome to the PulseAid listing for the Hysingla ER drug offered from Purdue Pharma LP. This Opioid Agonist [EPC],Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Purdue Pharma LP
NON-PROPRIETARY NAME: hydrocodone bitartrate
SUBSTANCE NAME: HYDROCODONE BITARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Opioid Agonist [EPC],Opioid Agonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-01-15
END MARKETING DATE: 0000-00-00


Hysingla ER HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHysingla ER from Purdue Pharma LP
LABELER NAME: Purdue Pharma LP
DEA SCHEDULE: CII
ACTIVE STRENGTH: 20(mg/1)
START MARKETING DATE: 2015-01-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59011-271_5ae3a057-7eb3-4166-8f76-3cf8d910ca9d
PRODUCT NDC: 59011-271
APPLICATION NUMBER: NDA206627

Other HYDROCODONE BITARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Pernix TherapeuticsZOHYDRO ER
Purdue Pharma LPHysingla ER
Zogenix, Inc.Zohydro